Texas Senate Bill SB306

Texas 2017 - 85th Regular

Caption

Relating to the continuation and functions of the Texas State Board of Pharmacy; authorizing a reduction in fees.

Impact

The enactment of SB306 is expected to solidify the authority of the Texas State Board of Pharmacy by extending its operational timeline until at least September 1, 2029. It enhances the state's ability to monitor prescription practices more effectively through digital means and introduces conditions under which pharmacy technicians can renew their registrations. By enforcing these regulations, SB306 aims to reduce instances of drug abuse and promote patient safety through better oversight of pharmacists' activities.

Summary

SB306, relating to the continuation and functions of the Texas State Board of Pharmacy, aims to enhance the oversight of pharmaceutical practices in Texas by implementing stricter guidelines for prescription monitoring and pharmacy technician registration. The bill emphasizes the significance of electronic tracking systems for controlled substances and mandates that pharmacists verify patient behaviors that may suggest abuse or diversion of drugs. Additionally, it outlines new training requirements for pharmacy board members to ensure compliance with updated laws and practices.

Contention

Despite its benefits, SB306 has faced some contention, particularly concerning the increased regulatory burden on pharmacists and pharmacy technicians. Critics argue that the additional training and monitoring requirements might hinder access to medications for patients. Furthermore, the balancing act between ensuring public safety and avoiding excessive regulation creates a nuanced debate within legislative circles. Stakeholders are divided on whether the provisions within the bill will adequately address concerns surrounding pharmaceutical oversight without imposing significant operational challenges for providers.